JESSICA TOTIN: Open Payments
NPI 1942965256 · BOARDMAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 66 payments from 15 companies in 2025. Trend: 2023 $1,570 · 2024 $2,033 · 2025 $1,229
Food & beverage: $1,229
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 16 | $279 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $207 |
| AstraZeneca Pharmaceuticals LP | 9 | $177 |
| Novartis Pharmaceuticals Corporation | 9 | $163 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| KYOWA KIRIN, INC. | 3 | $65 |
| Ardelyx, Inc. | 3 | $56 |
| Travere Therapeutics, Inc. | 1 | $35 |
| SCPHARMACEUTICALS INC. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: TARPEYO, Kerendia, FARXIGA, Fabhalta, JYNARQUE, CRYSVITA, Vanrafia, LOKELMA.
Industry payments across OH — which companies pay providers there.
